Mawson Infrastructure Group Inc. — Director's Dealing 2019

Apr 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2019-03-31

Reporting Person: Danenberg Noam (Director, Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-31	Restricted Stock Units (RSU)	$	A	140000	Acquired		Common Stock (140000)	Direct

Footnotes

F1: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock.

F2: Vest quarterly over a two year period commencing on the date of grant.

F3: Includes RSUs issued to Danenberg Holdings.